Core Viewpoint - Nestlé has initiated a recall of infant formula products in over 50 countries due to potential risks associated with the core nutritional additive ARA (Arachidonic Acid), raising concerns about raw material safety and supply chain management in the infant formula sector [1] Group 1: Company Responses - Feihe stated that all products containing ARA are safe for consumption and that their ARA is in powdered form, unlike the liquid ARA used in the recalled products [3] - Mengniu confirmed that their ARA suppliers are unrelated to the European recall incident and that all products undergo multiple quality checks before market release [3] - Danone emphasized that all their infant formula products are produced under high standards and do not use ARA from the implicated supplier [4] - Arla conducted a comprehensive review of their infant nutrition products and confirmed that their ARA is not affected by the issues related to the recall [4] Group 2: Regulatory Oversight - The State Council's Food Safety Office and the Market Supervision Administration have urged Nestlé (China) to effectively manage the recall of affected products, ensuring consumer rights are protected [2] - The recall in China involves four brands: Litojing, Platinum Enfamil, Shuyi Enfamil, and Wyeth S-26, totaling 30 batches of products [2] Group 3: Industry Implications - The incident highlights the urgent need for improved transparency in the food supply chain and the establishment of robust raw material traceability mechanisms [4] - There is a collective call for companies to strengthen their quality control systems and fulfill their responsibilities to maintain consumer confidence and ensure the healthy development of the industry [4]

财经频道更多独家策划、专家专栏，免费查阅>> 责任编辑：小讯 1月9日，针对雀巢多国召回婴幼儿配方奶粉，可能受到涉事ARA原料商波及的情况，海普诺凯在其电 商平台京东自营旗舰店提示：公司在售产品均采用粉状ARA作为原料，无蜡样芽孢杆菌相关问题，与 涉事企业自愿召回产品采用的液态ARA非同一种。公司产品上市前均通过中国监管体系的多重质量检 验，并接受国家权威机构的严格检测与监管，请放心食用。 ...

Core Viewpoint - Nestlé has initiated a global recall of infant formula products due to potential quality issues with ARA (Arachidonic Acid) sourced from suppliers, affecting over 50 countries and raising public concern about the safety of infant formula ingredients [1] Group 1: Company Responses - Mengniu stated that its ARA raw material suppliers are unrelated to the European recall incident, and all products undergo strict quality control [3] - Feihe confirmed that its ARA raw materials are not affected by any issues related to Bacillus cereus toxins, and the company adheres to stringent quality standards [3] - Junlebao mentioned that its ARA suppliers are Roget and Runke Bio, and the company follows internal control standards that exceed national regulations [3] - Danone emphasized that all its infant formula products are produced under high standards and do not use ARA from the suppliers involved in the recall [4] - Arla conducted a comprehensive review of its infant nutrition products and confirmed that its ARA suppliers are not linked to the recall issues [4] - HiPP stated that the ARA used in its products is sourced from suppliers not involved in the recall, ensuring safety and reliability [4] Group 2: Regulatory Oversight - The State Council's Food Safety Office and the Market Supervision Administration have urged Nestlé (China) to effectively manage the recall of affected products in China, ensuring consumer rights are protected [2] - The recall in the Chinese market includes four brands: Litojing, Platinum Enfamil, Shuyi Enfamil, and Wyeth's children's growth milk powder, totaling 30 batches [2]

Core Viewpoint - Nestlé Group announced a recall of infant formula products in 31 countries due to potential contamination with a toxin from arachidonic acid (ARA) oil supplied by a vendor, which could cause digestive issues [1][4] Company Impact - Jia Bi You, the largest ARA supplier in China, experienced a significant stock price drop of over 13% on January 8, with a maximum intraday decline of 14.15%, closing down 11.91% [1][5] - Jia Bi You's ARA business is crucial, projected to generate 390 million yuan in revenue for 2024, accounting for 70.27% of total revenue with a gross margin of 44.08% [2][5] - The company has long-term partnerships with major dairy brands like Nestlé and Danone, with some relationships exceeding 10 years, covering over 30 countries [2][5] Industry Response - Following the recall, several dairy companies, including Danone, Friesland, Junlebao, Yili, and Mengniu, issued clarifications distancing themselves from the implicated supplier [6] - Danone confirmed it does not use ARA raw materials from the affected supplier, while Junlebao and Yili highlighted their different ARA suppliers, indicating the substitutability of ARA suppliers and the risk of customer attrition for Jia Bi You [6] - DSM-Firmenich, a major competitor in the ARA market, reported a surge in demand for its ARA raw materials and is coordinating production to meet market needs, further intensifying competition for Jia Bi You [3][6]

Core Viewpoint - Nestlé has initiated a precautionary recall of multiple batches of infant formula due to potential contamination of arachidonic acid (ARA) from suppliers with cereulide, a toxin produced by Bacillus cereus [2] Group 1: Company Responses - China Feihe stated that its ARA raw materials are not affected by any issues related to Bacillus cereus toxins and are safe for consumption [2] - Feihe emphasized that it uses powdered ARA as a raw material, which is different from the liquid ARA used by the foreign company involved in the recall [2] - The company adheres to internal quality standards that are stricter than EU standards, ensuring that all core raw materials undergo rigorous testing for microbial contamination, including Bacillus cereus, before production [2]

Summary of Key Points Core Viewpoint - On January 9, Sunshine Dairy conducted a block trade of 1.08 million shares, amounting to 15.4548 million yuan, which represented 10.81% of the total trading volume for the day. The transaction price was 14.31 yuan, reflecting a discount of 9.03% compared to the market closing price of 15.73 yuan [1]. Trading Details - The block trade occurred on January 9, 2026, with the following details: - **Security Code**: 001318 - **Security Name**: Sunshine Dairy - **Transaction Price**: 14.31 yuan - **Transaction Volume**: 1.08 million shares - **Total Transaction Amount**: 15.4548 million yuan - **Discount**: 9.03% from the closing price of 15.73 yuan [1][2]. Buyer and Seller Information - The buyers and sellers involved in the transactions included: - **Buyers**: - Guotou Securities Co., Ltd. - CITIC Securities Co., Ltd. - Institutional investors - **Sellers**: - Dongxing Securities Co., Ltd. [2].

美素佳儿母公司荷兰皇家菲仕兰，荷兰超70%牧场为美素佳儿自家牧场。乳原料和部分重要营养素(如 ARA/DHA)全自供)。从牧场到餐桌的全产业链严苛的管理和品控，经过荷兰和中国政府的双重检验。 一万余名会员奶农均需接受5年以上农牧业专业教育，严格遵循菲仕兰FOQUS全链条质量管控体系的 200余项准则，涵盖动物福利、饲料安全、环境可持续等多个维度。该体系明确要求每头奶牛每日6小时 户外放牧，奶农需详细记录放牧时间，由第三方机构Qlip进行独立评定，菲仕兰同步开展监管与乳业协 暗访监督，确保标准落地。 随着婴幼儿配方乳粉行业监管趋严与消费需求升级，原料安全与供应链可控性已成为衡量品牌核心竞争 力的关键指标。市场监管总局2025年发布的《关于进一步加强婴幼儿配方乳粉原辅料管理有关事宜的公 告》明确提出，婴配乳粉生产企业应依法依规建立生产质量管理体系，设立原辅料质量安全控制要求， 完善原辅料采购验收管理制度。在此行业背景下，荷兰皇家菲仕兰旗下美素佳儿依托百年乳业积淀，构 建全链路自主生产配料体系，以高于国际标准的品质管控，持续回应新生代父母对奶粉安全的核心关 切，树立行业品质标杆。 作为深耕中国市场的国际乳业品牌，美 ...

Core Viewpoint - The company, Yili Group, confirmed that there are no issues with ARA (Arachidonic Acid) in its infant formula products, and its production and operations are running normally [1] Group 1: Product Assurance - Yili Group's infant formula products include Jinlingguan Zhenhu, Jinlingguan Zhenhu Platinum, Jinlingguan Senamu, Jinlingguan Jinghu, Jinlingguan Yuhu, Jinlingguan Youzi Little Sheep, and Jinlingguan Tofier Special Medical Series [1]

【编者按】 打造生命全阶段营养呵护体系 2003年，澳优在望城成立。由于地处非"黄金奶源带"，澳优将自身定位为一家依托全球优质资源实现发展的企 业。2009年，澳优在港交所主板上市，成为首家在港上市的婴幼儿配方奶粉企业。有了资本注入，澳优的国际化 发展开启加速跑—— 2011年，收购荷兰百年乳企海普诺凯集团；2016年，收购澳大利亚Nutrition Care，进入保健食品领域；2017年， 收购澳大利亚ADP奶粉工厂及Ozfarm公司，加大澳洲布局；2022年，收购荷兰羊奶酪公司Amalthea Group，助力 产品组合从原有羊奶粉产品延伸到奶酪产品。 由长沙市工业和信息化局、中共长沙市直属机关工作委员会、长沙市商务局、长沙市总工会联合主办的"共享计 划"长株潭好物乐购汇，将于2026年1月16日至18日在长沙红星国际会展中心举办。 活动前夕，长沙晚报特别组织品鉴团，发起"带你去探厂・长株潭好物溯源"系列活动。我们将带领市民走进澳优 乳业、可孚医疗、梦洁家纺、格力电器、浏阳"金阳好物"等植根于长株潭的名优工业消费品企业，共赴一场品质 与诚意的消费之约，在沉浸式体验中增进对"家门口"好物的认知与信赖。走进工 ...

瑞士雀巢因核心原料污染风险在全球31国召回奶粉的消息，像一枚投入平静湖面的石子，其涟漪迅速从 欧洲扩散至全球。当消费者的目光聚焦于"蜡样芽孢杆菌"与"预防性召回"等术语时，行业内的审视则穿 透成品，直抵现代食品工业最脆弱的命门——高度全球化且环节隐秘的上游核心原料供应链。 此次风波中，一家中国奶粉企业早年在关键原料上"不计成本"的投入与由此衍生的战略路径，为观察这 场全球供应链安全危机，提供了一个独特的"中国样本"。 引入顶级原料，并未让企业高枕无忧。相反，随着对ARA、DHA等核心营养素认知的加深，以及全球 供应链波动的现实，依赖单一海外巨头供应的模式，其潜在风险日益凸显。 价格受制于人仅是表象，更深层的是技术壁垒下的"安全黑箱"与供应稳定性风险。 企业无法深入参与 其生产过程，对质量文化的细节把控更是隔山望海。此次雀巢事件，正是这种"黑箱"风险的一次集中爆 发：一家上游原料供应商的品控疏漏，足以让下游巨头的全球产品网络陷入被动。 正是基于这种前瞻性的风险洞察，早期的"引进者"开始了漫长的"消化、吸收、再创新"之路。以圣元为 例，其路径清晰呈现了从"买家"到"掌控者"的转变：通过战略投资，与国内顶尖科研团队 ...